logoTry Persana

Lavo Life Sciences - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Lavo Life Sciences including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Lavo Life Sciences company logo

AI-accelerated quantum chemistry for rapid drug development.

Lavo Life Sciences focuses on AI-accelerated quantum chemistry for rapid drug development, enabling pharmaceutical companies to develop more drugs faster.

HeadquartersSan Francisco, California, United States
Team size1-10
FoundedNA

What is Lavo Life Sciences? - Company Overview & Details

Lavo Life Sciences is Lavo Life Sciences focuses on AI-accelerated quantum chemistry for rapid drug development, enabling pharmaceutical companies to develop more drugs faster., the company is headquartered in San Francisco, California, United States.

Who Founded Lavo Life Sciences?

Lavo Life Sciences was founded by Scott Swarthout, Zach Glick.

Who are the Key Executives at Lavo Life Sciences? - Leadership Team

Lavo Life Sciences is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Lavo Life Sciences

Scott SwarthoutCEO

Chief Technology Officer (CTO) of Lavo Life Sciences

Zach GlickCTO

About Scott Swarthout - CEO of Lavo Life Sciences

Scott Swarthout serves as the Chief Executive Officer of Lavo Life Sciences, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Lavo Life Sciences Company Details & Key Information

Where is Lavo Life Sciences located?

Lavo Life Sciences is headquartered in San Francisco, California, United States.

How many employees does Lavo Life Sciences have?

Lavo Life Sciences has 1-10 employees.

Lavo Life Sciences Official Website

How much funding has Lavo Life Sciences raised?

Lavo Life Sciences has raised $500,000 across 2 funding rounds. The most recent funding was completed on 2024-01-15.

Funding Overview

Lavo Life Sciences has successfully raised initial funding to support their innovative developments in drug formulation technologies.

$500,000
Total Funding Raised
2
Funding Rounds
2024-01-15
Latest Round

Lavo Life Sciences Funding History

Pre seed
2023-05-05
$500,000
Pre seed
2024-01-15

Who are the key investors in Lavo Life Sciences?

Lavo Life Sciences is backed by 1 key investors including Y Combinator. These investors focus on Technology, Biotech sectors.

Lavo Life Sciences Investor Overview

1
Key Investors
2
Focus Areas
3
Notable Investments

Complete List of Lavo Life Sciences Investors

Y Combinator

A renowned startup accelerator known for supporting early-stage companies.

Investment Focus
Technology
Biotech
Notable Portfolio Companies
Airbnb
Stripe
DoorDash

What sectors do Lavo Life Sciences investors focus on?

The investors backing Lavo Life Sciences primarily focus on Technology, Biotech sectors.

Technology
Biotech

Featured Investor: Y Combinator

Y Combinator

A renowned startup accelerator known for supporting early-stage companies.

Notable Investments: Airbnb, Stripe, DoorDash

What are Lavo Life Sciences's future plans?

Lavo Life Sciences Focus on further developing their Crystal Console and expanding their research capabilities.

Lavo Life Sciences Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Lavo Life Sciences face?

Lavo Life Sciences has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Lavo Life Sciences

1

Scaling operations

2

Attracting additional funding

What opportunities does Lavo Life Sciences have?

Lavo Life Sciences has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Lavo Life Sciences

1

Partnerships with pharmaceutical companies

2

Growing demand for drug development software

Lavo Life Sciences Strategic Position Summary

Key Focus Areas

Lavo Life Sciences is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Lavo Life Sciences?

Lavo Life Sciences has 2 recent news updates covering key business developments and market activities.

Lavo Life Sciences News Overview

2
Recent Articles
Active
Media Coverage
2025-01-21
Latest Update

What is Lavo Life Sciences in the news for?

Lavo Life Sciences is currently featured in news for Lavo Life Sciences Inc. launched Crystal Console on Jan 21st '25. and other significant business developments.

Recent News Articles About Lavo Life Sciences

Article 1
2025-01-21

Lavo Life Sciences Inc. launched Crystal Console on Jan 21st '25.

Lavo has launched the Crystal Console, a suite of tools for analyzing small molecule crystal data.

lavo.ai
Read News
Article 2
2024-03-26

Lavo's NSF SBIR Phase I grant awarded.

The Lavo team is thrilled to announce they have been awarded an NSF SBIR Phase I grant for their innovative CSP product.

Read News

Lavo Life Sciences FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Lavo Life Sciences including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Lavo Life Sciences Questions & Answers - Company Information

Q1

What is Lavo Life Sciences?

Lavo Life Sciences focuses on AI-accelerated quantum chemistry for rapid drug development, enabling pharmaceutical companies to develop more drugs faster.

Q2

Who founded Lavo Life Sciences?

Lavo Life Sciences was founded by Scott Swarthout, Zach Glick.

Q3

Who is the CEO of Lavo Life Sciences?

The CEO of Lavo Life Sciences is Scott Swarthout. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Lavo Life Sciences raised?

Lavo Life Sciences has raised a total of $$500,000 across 2 funding rounds. The most recent funding was completed on 2024-01-15.

Q5

Who are the investors in Lavo Life Sciences?

Lavo Life Sciences's key investors include Y Combinator.

Q6

Where is Lavo Life Sciences headquartered?

Lavo Life Sciences is headquartered in San Francisco, California, United States.

Q7

How many employees does Lavo Life Sciences have?

Lavo Life Sciences has 1-10 employees.

Q8

What is Lavo Life Sciences's official website?

You can visit Lavo Life Sciences's official website at https://www.lavo.ai/.

Q9

What was Lavo Life Sciences's latest funding round?

Lavo Life Sciences's latest funding round was a Pre seed round of $$500,000 completed on 2023-05-05.

Q10

Who is founder?

Scott Swarthout

Q11

Who is cto?

Zach Glick

Q12

What does the company do?

Lavo Life Sciences focuses on AI-accelerated quantum chemistry for rapid drug development.

Q13

How much funding?

$500,000

Q14

Latest funding date?

2024-01-15

Q15

Who are the investors?

Y Combinator

Q16

What are the challenges?

Scaling operations Attracting additional funding

Q17

What are the opportunities?

Partnerships with pharmaceutical companies Growing demand for drug development software

Q18

Latest news?

Lavo has launched the Crystal Console, a suite of tools for analyzing small molecule crystal data. The Lavo team is thrilled to announce they have been awarded an NSF SBIR Phase I grant for their innovative CSP product.

More Information About Lavo Life Sciences

For additional details about Lavo Life Sciences, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.